参考文献:
Skåne University Hospital. First patient treated with stem cell-derived nerve cells in Parkinson's disease STEM-PD trial. 2023.
Kirkeby A, et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. Cell Stem Cell. 2023.
Swedish Medical Products Agency. Clinical trial authorisation for STEM-PD (EudraCT 2021-001366-38). 2022.
Gesine Paul-Visse, et al. STEM-PD I/IIa clinical trial protocol. Lund University. 2022.